Richard Vial

521 total citations
11 papers, 406 citations indexed

About

Richard Vial is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Hematology. According to data from OpenAlex, Richard Vial has authored 11 papers receiving a total of 406 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 3 papers in Public Health, Environmental and Occupational Health and 3 papers in Hematology. Recurrent topics in Richard Vial's work include Acute Myeloid Leukemia Research (3 papers), Hormonal and reproductive studies (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Richard Vial is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Hormonal and reproductive studies (2 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Richard Vial collaborates with scholars based in United States. Richard Vial's co-authors include Alfredo Lopez‐S, Louis Balart, G. Arroyave, Donna H. Ryan, Michael R. Grever, Harry E. Hynes, John M. Rainey, Kenneth J. Kopecky, Alan Lichtin and David R. Head and has published in prestigious journals such as Cancer, Clinical Chemistry and Academic Medicine.

In The Last Decade

Richard Vial

11 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Vial United States 8 125 108 89 81 78 11 406
Wellington L. Paul United States 8 27 0.2× 170 1.6× 96 1.1× 7 0.1× 127 1.6× 13 483
Carmine Brienza Italy 6 56 0.4× 88 0.8× 123 1.4× 22 0.3× 46 0.6× 8 364
Marcello Sciaraffia Italy 10 81 0.6× 138 1.3× 29 0.3× 16 0.2× 35 0.4× 12 380
R. Müller Germany 11 45 0.4× 106 1.0× 15 0.2× 12 0.1× 15 0.2× 26 325
L.-E. Lins Sweden 9 57 0.5× 39 0.4× 33 0.4× 14 0.2× 6 0.1× 17 343
Raymond Gambino United States 9 69 0.6× 179 1.7× 67 0.8× 5 0.1× 17 0.2× 16 420
M Miltényi Hungary 10 64 0.5× 46 0.4× 11 0.1× 22 0.3× 13 0.2× 40 308
G.F. Gensini Italy 12 43 0.3× 31 0.3× 60 0.7× 19 0.2× 7 0.1× 35 331
Niva Jaccard Israel 9 42 0.3× 122 1.1× 5 0.1× 24 0.3× 59 0.8× 10 609
Rui‐Xiang Zeng China 12 47 0.4× 63 0.6× 28 0.3× 5 0.1× 19 0.2× 34 408

Countries citing papers authored by Richard Vial

Since Specialization
Citations

This map shows the geographic impact of Richard Vial's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Vial with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Vial more than expected).

Fields of papers citing papers by Richard Vial

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Vial. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Vial. The network helps show where Richard Vial may publish in the future.

Co-authorship network of co-authors of Richard Vial

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Vial. A scholar is included among the top collaborators of Richard Vial based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Vial. Richard Vial is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Karanes, Chatchada, Kenneth J. Kopecky, David R. Head, et al.. (1999). A phase III comparison of high dose ARA-C (HIDAC) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia. Leukemia Research. 23(9). 787–794. 64 indexed citations
2.
Vial, Richard, et al.. (1998). Cavernous Sinus Syndrome Due to Metastatic Renal Cell Carcinoma. Southern Medical Journal. 91(6). 576–579. 9 indexed citations
3.
Ryan, Donna H., Kenneth J. Kopecky, David Head, et al.. (1992). Analysis of Treatment Failure in Acute Nonlymphocytic Leukemia Patients over Fifty Years of Age. American Journal of Clinical Oncology. 15(1). 69–75. 14 indexed citations
4.
Kao, Yuan, et al.. (1990). Trisomy 4 in a case of acute undifferentiated myeloblastic leukemia with hand-mirror cells. Cancer Genetics and Cytogenetics. 45(2). 265–268. 10 indexed citations
5.
Plauché, Warren C., et al.. (1989). Two ways to assess problems of evaluating third- and fourth-year medical students. Academic Medicine. 64(8). 463–7. 3 indexed citations
6.
Amare, Mammo, W. J. Stuckey, John H. Saiki, et al.. (1982). Adriamycin combined with 10-day Ara-C, vincristine, and prednisone (10-day ADOAP) in the treatment of adult acute leukemia patients under fifty years of age A Southwest Oncology Group Study. American Journal of Clinical Oncology. 5(6). 641–644. 2 indexed citations
7.
Rainey, John M., et al.. (1981). Ifosfamide: a weekly dose fractionated schedule in bronchogenic carcinoma.. PubMed. 65(7-8). 693–5. 42 indexed citations
8.
Rainey, John M., et al.. (1979). A noninvasive technique for monitoring response to chemotherapy in human acute leukemia. Cancer. 44(3). 873–880. 7 indexed citations
9.
Lopez‐S, Alfredo, Richard Vial, Louis Balart, & G. Arroyave. (1974). Effect of exercise and physical fitness on serum lipids and lipoproteins. Atherosclerosis. 20(1). 1–9. 236 indexed citations
10.
Vial, Richard, et al.. (1971). Automated Simultaneous Turbidimetric Determination of Cholesterol in β- and pre-β-Lipoproteins. Clinical Chemistry. 17(10). 994–997. 9 indexed citations
11.
Vial, Richard, et al.. (1971). Automated simultaneous turbidimetric determination of cholesterol in beta- and pre-beta-lipoproteins.. PubMed. 17(10). 994–7. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026